MedTrace Logo

Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals

NCT06623032 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-03-10

No results posted yet for this study

Summary

The aim of this project is to investigate the physiological effects of intake of long-chain fatty acids (LCFA) and medium-chain fatty acids (MCFA) in patients with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) and healthy individuals

Conditions

  • Medium-chain Acyl-CoA Dehydrogenase Deficiency

Interventions

OTHER

Medium-Chain Fatty Acid (MCFA)

The participants will consume Medium-Chain Fatty Acid (MCFA) followed by Long-Chain Fatty Acid (LCFA)

OTHER

Long-Chain Fatty Acid (LCFA)

The participants will consume Long-Chain Fatty Acid (LCFA) followed by Medium-Chain Fatty Acid (MCFA).

Sponsors & Collaborators

  • Copenhagen Neuromuscular Center

    collaborator UNKNOWN

  • Center of Inherited Metabolic Diseases, Copenhagen University Hospital Rigshospitalet

    collaborator UNKNOWN

  • Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Denmark

    collaborator UNKNOWN

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Andreas M Fritzen, Associate Professor · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-18
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06623032 on ClinicalTrials.gov